Guerbet S. A. (GBT) - Net Assets

Latest as of December 2025: €260.08 Million EUR ≈ $304.06 Million USD

Based on the latest financial reports, Guerbet S. A. (GBT) has net assets worth €260.08 Million EUR (≈ $304.06 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€930.02 Million ≈ $1.09 Billion USD) and total liabilities (€669.94 Million ≈ $783.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Guerbet S. A. tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets €260.08 Million
% of Total Assets 27.96%
Annual Growth Rate 3.74%
5-Year Change -35.8%
10-Year Change -17.38%
Growth Volatility 10.1

Guerbet S. A. - Net Assets Trend (2004–2025)

This chart illustrates how Guerbet S. A.'s net assets have evolved over time, based on quarterly financial data. See GBT defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Guerbet S. A. (2004–2025)

The table below shows the annual net assets of Guerbet S. A. from 2004 to 2025. For live valuation and market cap data, see GBT market cap.

Year Net Assets Change
2025-12-31 €260.08 Million
≈ $304.06 Million
-33.58%
2024-12-31 €391.57 Million
≈ $457.79 Million
+3.52%
2023-12-31 €378.27 Million
≈ $442.24 Million
-0.34%
2022-12-31 €379.57 Million
≈ $443.76 Million
-6.30%
2021-12-31 €405.09 Million
≈ $473.60 Million
+10.15%
2020-12-31 €367.75 Million
≈ $429.94 Million
-5.51%
2019-12-31 €389.19 Million
≈ $455.01 Million
+6.12%
2018-12-31 €366.76 Million
≈ $428.78 Million
+7.20%
2017-12-31 €342.14 Million
≈ $400.00 Million
+8.69%
2016-12-31 €314.80 Million
≈ $368.03 Million
+11.46%
2015-12-31 €282.44 Million
≈ $330.20 Million
+9.01%
2014-12-31 €259.10 Million
≈ $302.92 Million
+8.75%
2013-12-31 €238.26 Million
≈ $278.55 Million
+5.33%
2012-12-31 €226.21 Million
≈ $264.46 Million
+5.31%
2011-12-31 €214.80 Million
≈ $251.12 Million
+2.03%
2010-12-31 €210.52 Million
≈ $246.12 Million
+2.54%
2009-12-31 €205.31 Million
≈ $240.02 Million
+10.54%
2008-12-31 €185.73 Million
≈ $217.13 Million
+8.64%
2007-12-31 €170.96 Million
≈ $199.86 Million
+12.37%
2006-12-31 €152.14 Million
≈ $177.86 Million
+7.78%
2005-12-31 €141.16 Million
≈ $165.03 Million
+17.43%
2004-12-31 €120.21 Million
≈ $140.54 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Guerbet S. A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 356.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock €12.64 Million 4.73%
Other Comprehensive Income €286.62 Million 107.35%
Other Components €11.77 Million 4.41%
Total Equity €266.99 Million 100.00%

Guerbet S. A. Competitors by Market Cap

The table below lists competitors of Guerbet S. A. ranked by their market capitalization.

Company Market Cap
InflaRx N.V
F:IF0
$130.16 Million
Chongkundang
KO:001630
$130.18 Million
Chialin Precision Industrial Co Ltd
TWO:3310
$130.19 Million
Baozun Inc
F:2BZA
$130.21 Million
Wintermar Offshore Marine Tbk
JK:WINS
$129.94 Million
Orion Gold NL
JSE:ORN
$129.87 Million
CB Industrial Product Holding
KLSE:7076
$129.84 Million
Leo Systems
TWO:5410
$129.79 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Guerbet S. A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 394,237,000 to 266,994,000, a change of -127,243,000 (-32.3%).
  • Net loss of 108,331,000 reduced equity.
  • Other comprehensive income decreased equity by 30,744,000.
  • Other factors increased equity by 11,832,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €-108.33 Million -40.57%
Other Comprehensive Income €-30.74 Million -11.51%
Other Changes €11.83 Million +4.43%
Total Change €- -32.28%

Book Value vs Market Value Analysis

This analysis compares Guerbet S. A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.44x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.92x to 0.44x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 €10.00 €9.22 x
2005-12-31 €11.24 €9.22 x
2006-12-31 €12.13 €9.22 x
2007-12-31 €13.61 €9.22 x
2008-12-31 €14.89 €9.22 x
2009-12-31 €16.35 €9.22 x
2010-12-31 €16.86 €9.22 x
2011-12-31 €16.47 €9.22 x
2012-12-31 €17.75 €9.22 x
2013-12-31 €18.73 €9.22 x
2014-12-31 €20.41 €9.22 x
2015-12-31 €22.52 €9.22 x
2016-12-31 €24.85 €9.22 x
2017-12-31 €27.01 €9.22 x
2018-12-31 €28.96 €9.22 x
2019-12-31 €30.73 €9.22 x
2020-12-31 €29.04 €9.22 x
2021-12-31 €32.05 €9.22 x
2022-12-31 €30.08 €9.22 x
2023-12-31 €30.08 €9.22 x
2024-12-31 €31.28 €9.22 x
2025-12-31 €21.15 €9.22 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Guerbet S. A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -40.57%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -13.78%
  • • Asset Turnover: 0.85x
  • • Equity Multiplier: 3.48x
  • Recent ROE (-40.57%) is below the historical average (6.75%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 14.31% 6.95% 0.97x 2.13x €5.18 Million
2005 16.30% 8.54% 0.91x 2.10x €8.90 Million
2006 12.44% 6.54% 0.89x 2.15x €3.71 Million
2007 13.90% 7.78% 0.86x 2.09x €6.67 Million
2008 13.13% 7.60% 0.84x 2.06x €5.82 Million
2009 9.98% 6.11% 0.85x 1.92x €-35.60K
2010 2.79% 1.67% 0.84x 2.00x €-15.17 Million
2011 6.72% 3.82% 0.84x 2.09x €-7.05 Million
2012 9.02% 5.05% 0.88x 2.04x €-2.22 Million
2013 8.60% 5.25% 0.85x 1.93x €-3.34 Million
2014 10.08% 6.38% 0.86x 1.84x €216.60K
2015 14.14% 8.15% 0.54x 3.20x €11.68 Million
2016 9.19% 3.73% 0.76x 3.27x €-2.55 Million
2017 13.51% 5.72% 0.85x 2.79x €12.00 Million
2018 12.77% 5.89% 0.74x 2.95x €10.14 Million
2019 9.59% 4.57% 0.81x 2.59x €-1.59 Million
2020 4.96% 2.56% 0.75x 2.57x €-18.54 Million
2021 8.06% 4.43% 0.74x 2.47x €-7.87 Million
2022 -10.83% -5.34% 0.82x 2.48x €-79.07 Million
2023 6.31% 3.00% 0.78x 2.71x €-13.97 Million
2024 4.08% 1.89% 0.82x 2.63x €-23.34 Million
2025 -40.57% -13.78% 0.85x 3.48x €-135.03 Million

Industry Comparison

This section compares Guerbet S. A.'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $19,365,365
  • Average return on equity (ROE) among peers: -141.14%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Guerbet S. A. (GBT) €260.08 Million 14.31% 2.58x $130.08 Million
Affluent Medical SAS (AFME) $31.47 Million -49.74% 0.80x $110.43 Million
Biosynex (ALBIO) $66.29 Million 47.32% 0.90x $15.74 Million
Bluelinea SA (ALBLU) $2.68 Million -60.39% 3.04x $9.00 Million
Carmat (ALCAR) $1.40 Million -1250.42% 5.16x $6.37 Million
Diagnostic Medical Systems SA (ALDMS) $25.27 Million -10.60% 0.84x $34.47 Million
Eurobio Scientific SA (ALERS) $18.07 Million -40.63% 1.08x $236.10 Million
Ikonisys SA (ALIKO) $15.73 Million -14.41% 0.33x $21.30 Million
Implanet SA (ALIMP) $-174.00K 0.00% 0.00x $28.16 Million
Mediantechn (ALMDT) $-7.25 Million 0.00% 0.00x $183.29 Million
Mauna Kea Technologies SAS (ALMKT) $40.16 Million -32.51% 0.22x $28.43 Million

About Guerbet S. A.

PA:GBT France Medical Devices
Market Cap
$135.87 Million
€116.22 Million EUR
Market Cap Rank
#18269 Global
#271 in France
Share Price
€9.22
Change (1 day)
-1.91%
52-Week Range
€8.20 - €23.55
All Time High
€76.51
About

Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced MRI examinations; Elucirem, a macrocyclic gadolinium-based contrast agent for use in contrast-enhanced resonance imaging; UNIK, a diagnostic imaging interconne… Read more